• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. Jan 1995; 39(1): 1–8.
PMCID: PMC162475

Resistance of Candida species to fluconazole.

Full Text

The Full Text of this article is available as a PDF (210K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abrahamsen TG, Widing E, Glomstein A, Gaustad P. Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia. Scand J Infect Dis. 1992;24(3):391–393. [PubMed]
  • Akova M, Akalin HE, Uzun O, Hayran M, Tekuzman G, Kansu E, Aslan S, Telatar H. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome. Clin Infect Dis. 1994 Mar;18(3):298–304. [PubMed]
  • Akova M, Akalin HE, Uzun O, Gür D. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):598–599. [PubMed]
  • Anaissie EJ, Karyotakis NC, Hachem R, Dignani MC, Rex JH, Paetznick V. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J Infect Dis. 1994 Aug;170(2):384–389. [PubMed]
  • Ansari AM, Gould IM, Douglas JG. High dose oral fluconazole for oropharyngeal candidosis in AIDS. J Antimicrob Chemother. 1990 Apr;25(4):720–721. [PubMed]
  • Arilla MC, Carbonero JL, Schneider J, Regúlez P, Quindós G, Pontón J, Cisterna R. Vulvovaginal candidiasis refractory to treatment with fluconazole. Eur J Obstet Gynecol Reprod Biol. 1992 Mar 23;44(1):77–80. [PubMed]
  • Bailey EM, Krakovsky DJ, Rybak MJ. The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy. 1990;10(2):146–153. [PubMed]
  • Bailly MP, Boibieux A, Biron F, Durieu I, Piens MA, Peyramond D, Bertrand JL. Persistence of Cryptococcus neoformans in the prostate: failure of fluconazole despite high doses. J Infect Dis. 1991 Aug;164(2):435–436. [PubMed]
  • Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone WJ. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):86S–89S. [PubMed]
  • Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother. 1994 Jul;38(7):1530–1533. [PMC free article] [PubMed]
  • Barchiesi F, Giacometti A, Arzeni D, Branchesi P, Crescenzi G, Ancarani F, Scalise G. Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. J Chemother. 1992 Dec;4(6):381–386. [PubMed]
  • Barchiesi F, Morbiducci V, Ancarani F, Scalise G. Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients. Eur J Epidemiol. 1993 Jul;9(4):455–456. [PubMed]
  • Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol. 1993 Nov;31(11):2933–2937. [PMC free article] [PubMed]
  • Berry AJ, Rinaldi MG, Graybill JR. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother. 1992 Mar;36(3):690–692. [PMC free article] [PubMed]
  • Bignardi GE, Savage MA, Coker R, Davis SG. Fluconazole and Candida krusei infections. J Hosp Infect. 1991 Aug;18(4):326–327. [PubMed]
  • Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis. 1993 Dec;17(6):1018–1021. [PubMed]
  • Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990 Mar-Apr;12 (Suppl 3):S318–S326. [PubMed]
  • Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1993 Nov;37(11):2449–2453. [PMC free article] [PubMed]
  • Case CP, MacGowan AP, Brown NM, Reeves DS, Whitehead P, Felmingham D. Prophylactic oral fluconazole and candida fungaemia. Lancet. 1991 Mar 30;337(8744):790–790. [PubMed]
  • Coker RJ, Harris JR. Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels. J Infect. 1991 Jul;23(1):101–103. [PubMed]
  • Colville A, Wale MC. Fluconazole or amphotericin for candidaemia in non-neutropenic patients? Lancet. 1991 Jun 29;337(8757):1605–1606. [PubMed]
  • Dan M, Priel I. Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans. Clin Infect Dis. 1994 Jan;18(1):126–127. [PubMed]
  • Dupouy-Camet J, Paugam A, Di Donato C, Viguié C, Vicens I, Volle PJ, Tourte-Schaefer C. Résistance au fluconazole en milieu hospitalier. Concordance entre la résistance de Candida albicans in vitro et l'échec thérapeutique. Presse Med. 1991 Sep 14;20(28):1341–1341. [PubMed]
  • Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol. 1991 Jun;29(6):1089–1094. [PMC free article] [PubMed]
  • Evans TG, Mayer J, Cohen S, Classen D, Carroll K. Fluconazole failure in the treatment of invasive mycoses. J Infect Dis. 1991 Dec;164(6):1232–1235. [PubMed]
  • Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RH. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother. 1991 Nov;35(11):2302–2305. [PMC free article] [PubMed]
  • Fox R, Neal KR, Leen CL, Ellis ME, Mandal BK. Fluconazole resistant candida in AIDS. J Infect. 1991 Mar;22(2):201–204. [PubMed]
  • Glatt AE, Chirgwin K, Landesman SH. Current concepts. Treatment of infections associated with human immunodeficiency virus. N Engl J Med. 1988 Jun 2;318(22):1439–1448. [PubMed]
  • Goldman M, Pottage JC, Jr, Weaver DC. Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) 1993 May;72(3):143–150. [PubMed]
  • Graninger W, Presteril E, Schneeweiss B, Teleky B, Georgopoulos A. Treatment of Candida albicans fungaemia with fluconazole. J Infect. 1993 Mar;26(2):133–146. [PubMed]
  • Greenwood D. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis. 1981 Oct;144(4):380–385. [PubMed]
  • Harris SC, Wallace JE, Foulds G, Rinaldi MG. Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection. Antimicrob Agents Chemother. 1989 May;33(5):714–716. [PMC free article] [PubMed]
  • Heinic GS, Stevens DA, Greenspan D, MacPhail LA, Dodd CL, Stringari S, Strull WM, Hollander H. Fluconazole-resistant Candida in AIDS patients. Report of two cases. Oral Surg Oral Med Oral Pathol. 1993 Dec;76(6):711–715. [PubMed]
  • High KP, Quagliarello VJ. Yeast perinephric abscess: report of a case and review. Clin Infect Dis. 1992 Jul;15(1):128–133. [PubMed]
  • Hitchcock CA. Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans. 1993 Nov;21(4):1039–1047. [PubMed]
  • Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother. 1993 Sep;37(9):1962–1965. [PMC free article] [PubMed]
  • Horsburgh CR, Jr, Kirkpatrick CH. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med. 1983 Jan 24;74(1B):23–29. [PubMed]
  • Johnson EM, Richardson MD, Warnock DW. In-vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother. 1984 Jun;13(6):547–558. [PubMed]
  • Kitchen VS, Savage M, Harris JR. Candida albicans resistance in AIDS. J Infect. 1991 Mar;22(2):204–205. [PubMed]
  • Korting HC, Ollert M, Georgii A, Fröschl M. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol. 1988 Dec;26(12):2626–2631. [PMC free article] [PubMed]
  • Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis. 1990 Mar-Apr;12 (Suppl 3):S327–S333. [PubMed]
  • McIlroy MA. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis. J Infect Dis. 1991 Feb;163(2):420–421. [PubMed]
  • Meunier F, Aoun M, Gerard M. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Rev Infect Dis. 1990 Mar-Apr;12 (Suppl 3):S364–S368. [PubMed]
  • Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol. 1994 Apr;32(4):1115–1118. [PMC free article] [PubMed]
  • Ng TT, Denning DW. Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach. J Infect. 1993 Mar;26(2):117–125. [PubMed]
  • Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother. 1993 Apr;31(4):463–471. [PubMed]
  • Parente F, Ardizzone S, Cernuschi M, Antinori S, Esposito R, Moroni M, Lazzarin A, Bianchi Porro G. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. Am J Gastroenterol. 1994 Mar;89(3):416–420. [PubMed]
  • Parente F, Cernuschi M, Rizzardini G, Lazzarin A, Valsecchi L, Bianchi Porro G. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. Am J Gastroenterol. 1991 Dec;86(12):1729–1734. [PubMed]
  • Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida krusei fungemia. N Engl J Med. 1991 Oct 31;325(18):1315–1315. [PubMed]
  • Pfaller MA, Rhine-Chalberg J, Redding SW, Smith J, Farinacci G, Fothergill AW, Rinaldi MG. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol. 1994 Jan;32(1):59–64. [PMC free article] [PubMed]
  • Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother. 1994 Jun;38(6):1422–1424. [PMC free article] [PubMed]
  • Redding S, Smith J, Farinacci G, Rinaldi M, Fothergill A, Rhine-Chalberg J, Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis. 1994 Feb;18(2):240–242. [PubMed]
  • Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994 Nov 17;331(20):1325–1330. [PubMed]
  • Rex JH, Hanson LH, Amantea MA, Stevens DA, Bennett JE. Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography. Antimicrob Agents Chemother. 1991 May;35(5):846–850. [PMC free article] [PubMed]
  • Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother. 1995 Jan;39(1):40–44. [PMC free article] [PubMed]
  • Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev. 1993 Oct;6(4):367–381. [PMC free article] [PubMed]
  • Reynes J, Mallié M, André D, Janbon F, Bastide JM. Traitement et prophylaxie secondaire par fluconazole des candidoses oropharyngées des sujets VIH +. Analyse mycologique des echecs. Pathol Biol (Paris) 1992 May;40(5):513–517. [PubMed]
  • Røder BL, Sonnenschein C, Hartzen SH. Failure of fluconazole therapy in Candida krusei fungemia. Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):173–173. [PubMed]
  • Ruhnke M, Eigler A, Engelmann E, Geiseler B, Trautmann M. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection. 1994 Mar-Apr;22(2):132–136. [PubMed]
  • Saag MS, Dismukes WE. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988 Jan;32(1):1–8. [PMC free article] [PubMed]
  • Sandven P, Bjørneklett A, Maeland A. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother. 1993 Nov;37(11):2443–2448. [PMC free article] [PubMed]
  • Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994 Oct;97(4):339–346. [PubMed]
  • Sanguineti A, Carmichael JK, Campbell K. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med. 1993 May 10;153(9):1122–1124. [PubMed]
  • Siegman-Igra Y, Rabaw MY. Failure of fluconazole in systemic candidiasis. Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):201–202. [PubMed]
  • Smith D, Boag F, Midgley J, Gazzard B. Fluconazole resistant candida in AIDS. J Infect. 1991 Nov;23(3):345–346. [PubMed]
  • Smith KJ, Warnock DW, Kennedy CT, Johnson EM, Hopwood V, Van Cutsem J, Vanden Bossche H. Azole resistance in Candida albicans. J Med Vet Mycol. 1986 Apr;24(2):133–144. [PubMed]
  • Soutar RL. Fluconazole or amphotericin for candidosis in neutropenic patients. Lancet. 1991 Jan 19;337(8734):181–181. [PubMed]
  • Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med. 1991 Dec;151(12):2458–2464. [PubMed]
  • Troillet N, Durussel C, Bille J, Glauser MP, Chave JP. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):911–915. [PubMed]
  • vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother. 1992 Dec;36(12):2602–2610. [PMC free article] [PubMed]
  • Vuffray A, Durussel C, Boerlin P, Boerlin-Petzold F, Bille J, Glauser MP, Chave JP. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS. 1994 May;8(5):708–709. [PubMed]
  • Warnock DW, Burke J, Cope NJ, Johnson EM, von Fraunhofer NA, Williams EW. Fluconazole resistance in Candida glabrata. Lancet. 1988 Dec 3;2(8623):1310–1310. [PubMed]
  • White DJ, Johnson EM, Warnock DW. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin Med. 1993 Apr;69(2):112–114. [PMC free article] [PubMed]
  • Willocks L, Leen CL, Brettle RP, Urquhart D, Russell TB, Milne LJ. Fluconazole resistance in AIDS patients. J Antimicrob Chemother. 1991 Dec;28(6):937–939. [PubMed]
  • Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991 Oct 31;325(18):1274–1277. [PubMed]
  • Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother. 1993 Sep;37(9):1847–1849. [PMC free article] [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...